Clomiphene Citrate: An Old Favourite Lives On

Journal of Obstetrics and Gynaecology Canada

Volumn 29, Issue 8, 2007, Pages 617-618

  Rowe, Timothy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; CLOMIFENE; FERTILITY PROMOTING AGENT; LETROZOLE; NITRILE; TRIAZOLE DERIVATIVE;

AMENORRHEA; BODY COMPOSITION; CLINICAL PRACTICE; CONTRACEPTION; DRUG EFFICACY; DRUG POTENCY; EDITORIAL; GENERAL ANESTHESIA; GLUCOSE TOLERANCE; HAIR GROWTH; HUMAN; INFERTILITY; INSULIN SENSITIVITY; LAPAROTOMY; LOWER ABDOMINAL PAIN; MEDICAL SOCIETY; OVARY POLYCYSTIC DISEASE; PNEUMOPERITONEUM; PRACTICE GUIDELINE; PREGNANCY; PRIMARY MEDICAL CARE; X RAY; ANOVULATION; FEMALE; FEMALE INFERTILITY;

ANOVULATION; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; NITRILES; POLYCYSTIC OVARY SYNDROME; TRIAZOLES;

EID: 35248836598     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32557-9     Document Type: Editorial

References (13)

1. Stein I.F., Leventhal M.L. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935, 29:181-191.
2. Kistner R.W. Induction of ovulation with clomiphene citrate. Obstet Gynecol Surv 1965, Dec 20(6):873-900.
3. Hughes E., Collins J., Vandekerckhove P. Clomiphene citrate for ovulation induction in women with oligo-amenorrhea. Cochrane Database Syst Rev 2000, (2):CD000056.
4. Homburg R., Armar N.A., Eshel A., Adams J., Jacobs H.S. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988, 297:1024-1026.
5. Boomsma C.M., Eijkemans M.J., Hughes E.G., Visser G.H., Fauser B.C., Macklon N.S. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006, 12:673-683.
6. Barber T.M., McCarthy M.I., Wass J.A., Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006, 65:137-145.
7. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989, 38:1165-1174.
8. Dunaif A., Segal K.R., Shelley D.R., Green G., Dobrjansky A., Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992, 41:1257-1266.
9. Azziz R. Diagnosis of polycystic ovary syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006, 91:781-785.
10. Legro R.S., Barnhart H.X., Schlaff W.D., Carr B.R., Diamond M.P., Carson S.A., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007, 356:551-566.
11. Palomba S., Russo T., Orio F., Falbo A., Manguso F., Sammartino A., et al. Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study. Hum Reprod 2006, 21(11):2823-2829.
12. Bayar U., Basaran M., Kiran S., Coskun A., Gezer S. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertil Steril 2006, 86:1447-1451.
13. Al-Fozan H., Al-Khadouri M., Tan S.L., Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril 2004, 82:1561-1563.